ID: h-fa11c9bd1e
Hypothesis
HBOT (2.0 ATA, 60 min) activates TFEB-mediated autophagy-lysosome pathway to accelerate Aβ and p-tau clearance
HBOT increases mTORC1 inhibition, promoting TFEB nuclear translocation and enhancing autophagy flux to clear pathological proteins.
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 3 support✗ 2 oppose
✓ All Quality Gates Passed
🧪 Overview
HBOT increases mTORC1 inhibition, promoting TFEB nuclear translocation and enhancing autophagy flux to clear pathological proteins. However, autophagy markers are easily misinterpreted (increased LC3-II can mean blocked flux), and the direction of autophagy regulation by oxygen is context-dependent. Rigorous flux validation with insoluble Aβ/tau clearance endpoints is required.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["mTORC1 Hyperactivation<br/>Nutrient/Growth Signals"]
B["TFEB Phosphorylation<br/>Ser211 by mTORC1"]
C["14-3-3 Sequestration<br/>Cytoplasmic Retention"]
D["Lysosomal Biogenesis<br/>Blocked"]
E["Autophagic Flux<br/>Impaired"]
F["Tau/Amyloid Aggregate<br/>Accumulation"]
G["TFEB Activation<br/>Rapamycin or MCOLN1"]
H["Nuclear TFEB<br/>CLEAR Gene Expression"]
G --> H
H -.->|"rescues"| D
A --> B
B --> C
C --> D
D --> E
E --> F
style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style G fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style H fill:#1b5e20,stroke:#81c784,color:#81c784⚖️ Evidence
⚖️ Evidence Matrix3 supports2 contradicts
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — TFEB
No curated PDB or AlphaFold mapping for TFEB yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for TFEB (TFE2) from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for TFEB (TFE2).
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
—
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▼ 0.2%
Volatility
Low
0.0048
Events (7d)
2
Price History
▼5.2%💾 Resource Usage
LLM Tokens
11,804
$0.0354
Total Cost
$0.0354
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF APP/PS1 transgenic mice receive HBOT (2.0 ATA, 60 min per session, 5 sessions/week for 4 weeks), THEN cortical insoluble Aβ42 levels will decrease by ≥30% compared to sham-treated littermate contro | ≥30% reduction in cortical insoluble Aβ42; TFEB nuclear localization increase ≥1.8-fold in cortical neurons; LC3-II/p62 ratio increased ≥1.5-fold indicating enh | — no observation — | pending | 0.62 |
| IF SH-SY5Y neuroblastoma cells with doxycycline-inducible TFEB overexpression are subjected to HBOT (2.0 ATA, 60 min) in a hyperbaric chamber, THEN lysosomal protease activity (Cathepsin D) will incre | Cathepsin D activity ≥2-fold; BODIPY-casein cleavage rate ≥40% increase; TFEB nuclear/cytosol ratio ≥2.5-fold; p62 half-life decreased by ≥50% indicating active | — no observation — | pending | 0.58 |
🔮 Falsifiable Predictions (2)
pendingconf 62%
IF APP/PS1 transgenic mice receive HBOT (2.0 ATA, 60 min per session, 5 sessions/week for 4 weeks), THEN cortical insoluble Aβ42 levels will decrease by ≥30% compared to sham-treated littermate controls within 2 weeks after the final session, because TFEB nuclear translocation drives autophagy-media
Predicted outcome: ≥30% reduction in cortical insoluble Aβ42; TFEB nuclear localization increase ≥1.8-fold in cortical neurons; LC3-II/p62 ratio increased ≥1.5-fold indi
Falsification: Insoluble Aβ42 unchanged or increased; TFEB remains cytosolic; LC3-II increases but p62 also accumulates (blocked flux pattern); any one failure disproves the mechanism
pendingconf 58%
IF SH-SY5Y neuroblastoma cells with doxycycline-inducible TFEB overexpression are subjected to HBOT (2.0 ATA, 60 min) in a hyperbaric chamber, THEN lysosomal protease activity (Cathepsin D) will increase ≥2-fold and long-lived protein degradation rate will increase ≥40% within 24 hours post-treatmen
Predicted outcome: Cathepsin D activity ≥2-fold; BODIPY-casein cleavage rate ≥40% increase; TFEB nuclear/cytosol ratio ≥2.5-fold; p62 half-life decreased by ≥50% indicat
Falsification: Cathepsin D activity unchanged; protein degradation rate unchanged or decreased despite LC3-II increase; p62 stable or increased (indicating flux blockade); any one failure disproves the mechanism
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.